No Data
No Data
Director Cashes In on Xeris Pharmaceuticals Stock!
Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game
Calculating The Fair Value Of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS)
Express News | Xeris Biopharma Holdings Inc - Gvoke Vialdx Expected to Be Available in Q3 2025
Xeris Announces FDA Approval Of Supplemental New Drug Application Of Gvoke VialDx For Use As A Diagnostic Aid; Xeris Also Announced It Has Partnered With American Regent To Commercialize Gvoke VialDx; Financial Terms Were Not Disclosed
Express News | Xeris Announces Approval of Supplemental New Drug Application (Snda) of Gvoke Vialdx™ (Glucagon) for Use as a Diagnostic Aid